Literature DB >> 18696089

[Adult onset Still's disease].

B Manger1.   

Abstract

Adult onset Still's disease is a rare, febrile, multisystem rheumatic disease with unknown etiology, which runs an intermittent course and can either go into remission after months to years or progress to a chronic course with substantial joint destruction. The prevalence of this disease has been increasing in the last decade presumably caused by better diagnostic tools but also by a higher awareness among physicians taking care of patients with "fever of unknown origin". This review is intended to augment this trend, since research on the role of proinflammatory cytokines in this disease has led to an improved diagnostic and therapeutic repertoire over the last few years. Ferritin and interleukin-18 serum levels are valuable diagnostic parameters and blockade of interleukin-1, interleukin-6, and tumor-necrosis-factor alpha can effectively control the inflammatory activity of this disease in most cases and also in life-threatening conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696089     DOI: 10.1007/s00393-008-0325-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  54 in total

1.  Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.

Authors:  Masahiro Iwamoto; Hiroyuki Nara; Daisuke Hirata; Seiji Minota; Norihiro Nishimoto; Kazuyuki Yoshizaki
Journal:  Arthritis Rheum       Date:  2002-12

2.  Refractory adult onset Still's disease successfully treated with anakinra.

Authors:  F M Vasques Godinho; M J Parreira Santos; J Canas da Silva
Journal:  Ann Rheum Dis       Date:  2004-09-16       Impact factor: 19.103

3.  Acute respiratory failure revealing adult-onset Still's disease: diagnostic value of low glycosylated ferritin level.

Authors:  Charlotte Biron; Arnaud Chambellan; Christian Agard; Michele Denis; Patrick Germaud; Mohamed A Hamidou
Journal:  Clin Rheumatol       Date:  2005-11-10       Impact factor: 2.980

4.  Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.

Authors:  Pedro J Ruiz; Eliezer Masliah; Taylor A Doherty; Ai Quach; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

5.  Crico-thyroid perichondritis leading to sore throat in patients with active adult-onset Still's disease.

Authors:  Der-Yuan Chen; Howard Haw-Chang Lan; Tsu-Yi Hsieh; Hsin-Hua Chen; Joung-Liang Lan
Journal:  Ann Rheum Dis       Date:  2007-09       Impact factor: 19.103

6.  Double-filtration plasmapheresis for resolution of corticosteroid resistant adult onset Still's disease.

Authors:  Takashi Kato; Tatsuo Kobayashi; Hiroshi Nishino; Yuji Hidaka
Journal:  Clin Rheumatol       Date:  2006-03-28       Impact factor: 2.980

7.  Cardiac tamponade: a life-threatening complication of Still's disease.

Authors:  F Najam; H A Fuchs
Journal:  J Clin Rheumatol       Date:  2001-04       Impact factor: 3.517

8.  Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report.

Authors:  S Guignard; G Dien; M Dougados
Journal:  Clin Exp Rheumatol       Date:  2007 Sep-Oct       Impact factor: 4.473

9.  Epidemiology and outcome of adult-onset Still's disease in Northern Norway.

Authors:  K J Evensen; H C Nossent
Journal:  Scand J Rheumatol       Date:  2006 Jan-Feb       Impact factor: 3.641

10.  Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia.

Authors:  Yohei Kirino; Mitsuhiro Takeno; Mika Iwasaki; Atsuhisa Ueda; Shigeru Ohno; Akira Shirai; Heiwa Kanamori; Katsuaki Tanaka; Yoshiaki Ishigatsubo
Journal:  Arthritis Res Ther       Date:  2005-03-21       Impact factor: 5.156

View more
  3 in total

1.  [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors:  B Manger; M Gaubitz; H Michels
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

2.  [Nonexudative pharyngitis with intermittent fever].

Authors:  A S Büchel; M Jungehülsing
Journal:  HNO       Date:  2021-08       Impact factor: 1.284

Review 3.  [Periodic fever syndrome/autoinflammatory syndrome].

Authors:  I Kötter; J Schedel; J B Kümmerle-Deschner
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.